FDA Final Rule Amends Human & Vet Drug Labeling Requirements
The Food and Drug Administration has issued a final rule amending the packaging and labeling control provisions of the current good manufacturing practice (CGMP) regulations for human and veterinary drug products. The final rule amends 21 CFR Part 211 by limiting the application of special control procedures for the use of cut labeling to immediate container labels, individual unit cartons, or multiunit cartons containing immediate containers that are not packaged in individual unit cartons.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
FDA is also permitting the use of any automated technique, including differentiation by labeling size and shape, that physically prevents incorrect labeling from being processed by labeling and packaging equipment when cut labeling is used. The final rule is effective March 20, 2013, except for the provision permitting any automated technique to physically prevent incorrect labeling, which is effective April 19, 2012.
FDA Contact - Brian Hasselbalch (301) 796-3279, email brian.hasselbalch@fda.hhs.gov
(FR Pub 03/20/12)